17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
The Department of Housing and Community Development (DHCD) of Prince George’s County in Maryland is...
Read More >
The latest in a string of U.S. government (USG) actions restricting the use of Chinese technology in...
Read More >
In the March 2020 Visa Bulletin issued by the US Department of State, EB-2 worldwide employment-base...
Read More >
In the continued fallout from the “me too” movement, Connecticut Governor Ned Lamont has signed ne...
Read More >
On September 17, McDermott will host James McGinnis, managing director at PJ Solomon, and Salvo Vita...
Read More >
Beginning March 1, 2020, employers in countries other than the Netherlands in the European Economic ...
Read More >